{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:58:22Z","timestamp":1793843902411,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vaccine.2024.05.060","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T08:41:35Z","timestamp":1717144895000},"page":"126012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Seroprevalence of measles antibodies in the Italian general population in 2019\u20132020"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1200-2778","authenticated-orcid":false,"given":"Tiziana","family":"Grassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bagordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Dettori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7375-9187","authenticated-orcid":false,"given":"Tatjana","family":"Baldovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-7184","authenticated-orcid":false,"given":"Alessandra","family":"Panico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1279-6168","authenticated-orcid":false,"given":"Elvira","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6817-2461","authenticated-orcid":false,"given":"Serena","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Furfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palmira","family":"Immordino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Savio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7259-4923","authenticated-orcid":false,"given":"Giovanni","family":"Gabutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.060_b0005","unstructured":"World Health Organization (WHO). Measles. Key facts. 9 August 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/measles [accessed 16 November 2023]."},{"key":"10.1016\/j.vaccine.2024.05.060_b0010","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.15585\/mmwr.mm7045a1","article-title":"Progress toward regional measles elimination - worldwide, 2000\u20132020","volume":"70","author":"Dixon","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.05.060_b0015","unstructured":"European Centre for Disease Prevention and Control. Measles. in: ECDC. Annual Epidemiological Report for 2022. Stockholm: ECDC, 2023."},{"key":"10.1016\/j.vaccine.2024.05.060_b0020","unstructured":"Ministero della Salute. Aggiornamento del sistema di sorveglianza integrata del morbillo e della rosolia, per il rafforzamento degli obiettivi di eliminazione. 2018. https:\/\/www.trovanorme.salute.gov.it\/norme\/renderNormsanPdf?anno=2018&codLeg=66521&parte=1%20&serie=null [accessed 16 November 2023]."},{"key":"10.1016\/j.vaccine.2024.05.060_b0025","unstructured":"Legge 31 luglio 2017, n. 119. Conversione in legge, con modificazioni, del decreto-legge 7 giugno 2017, n. 73, recante disposizioni urgenti in materia di prevenzione vaccinale. Available at: https:\/\/www.trovanorme.salute.gov.it\/norme\/dettaglioAtto?id=60201&articolo=2."},{"key":"10.1016\/j.vaccine.2024.05.060_b0030","unstructured":"Istituto Superiore di Sanit\u00e0 (ISS). Morbillo e Rosolia news. Aggiornamento mensile. Rapporto n.67-febbraio 2023. https:\/\/www.epicentro.iss.it\/morbillo\/bollettino\/RM_News_2022_67.pdf [accessed 23 November 2023]."},{"key":"10.1016\/j.vaccine.2024.05.060_b0035","unstructured":"World Health Organization (WHO). Eleventh Meeting of the European Regional Verification Commission for Measles and Rubella elimination; 8-10 November 2022; Copenhagen: WHO Regional Office for Europe; 2023."},{"key":"10.1016\/j.vaccine.2024.05.060_b0040","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.15585\/mmwr.mm7147a1","article-title":"Progress toward regional measles elimination - worldwide, 2000\u20132021","volume":"71","author":"Minta","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.05.060_b0045","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/vaccines10122130","article-title":"Sero-Epidemiological Study Group. Sero-Epidemiological Study of Bordetella pertussis Infection in the Italian General Population","volume":"10","author":"Grassi","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.05.060_b0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/vaccines11020306","article-title":"Sero-Epidemiological Study Group. Sero-Epidemiological Study of Varicella in the Italian General Population","volume":"11","author":"Gabutti","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.05.060_b0055","first-page":"29","volume":"2","author":"Osborne","year":"1997","journal-title":"The European sero-epidemiology network Eurosurveill"},{"key":"10.1016\/j.vaccine.2024.05.060_b0060","unstructured":"World Health Organization (WHO). Measles and rubella strategic framework 2021\u20132030. Geneva: World Health Organization, 2020."},{"key":"10.1016\/j.vaccine.2024.05.060_b0065","unstructured":"World Health Organization (WHO). Measles outbreak strategic response plan 2012-2023. Geneva: WHO, 2021."},{"key":"10.1016\/j.vaccine.2024.05.060_b0070","unstructured":"World Health Organization (WHO). Measles outbreak guide. Geneva: WHO, 2022."},{"key":"10.1016\/j.vaccine.2024.05.060_b0075","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/pathogens12101192","article-title":"Measles resurgence in Europe: an open breakthrough in the field of vaccine-preventable diseases","volume":"12","author":"De Francesco","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2024.05.060_b0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/vaccines8020218","article-title":"Are the objectives proposed by the WHO for routine measles vaccination coverage and population measles immunity sufficient to achieve measles elimination from Europe?","volume":"8","author":"Plans-Rubi\u00f3","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.05.060_b0085","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1371\/journal.pmed.0020316","article-title":"A measles epidemic threshold in a highly vaccinated population","volume":"2","author":"Wallinga","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2024.05.060_b0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamapediatrics.2019.4357","article-title":"Factors associated with measles transmission in the United States during the post-elimination era","volume":"174","author":"Gasta\u00f1aduy","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2024.05.060_b0095","first-page":"950","article-title":"Pattern of susceptibility to measles in Italy. Serological Study Group","volume":"78","author":"Salmaso","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.05.060_b0100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/CDLI.9.3.693-697.2002","article-title":"Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals","volume":"9","author":"Isa","year":"2002","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.05.060_b0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/vaccines8010066","article-title":"Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy","volume":"8","author":"Anichini","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.05.060_b0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0950268801005234","article-title":"The seroepidemiology of measles in Western Europe","volume":"126","author":"de Melker","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2024.05.060_b0115","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1016\/j.vaccine.2008.05.094","article-title":"Ciofi degli Atti ML. Measles serological survey in the Italian population: interpretation of results using mixture model","volume":"26","author":"Rota","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.060_b0120","unstructured":"Istituto Superiore di Sanit\u00e0 (ISS). Morbillo & Rosolia News Aggiornamento mensile. Sorveglianza Integrata del Morbillo e della Rosolia. Rapporto N\u00b0 48 - Gennaio 2019. https:\/\/www.epicentro.iss.it\/morbillo\/bollettino\/RM_News_2018_48%20def.pdf [accessed 30 November 2023]."},{"key":"10.1016\/j.vaccine.2024.05.060_b0125","unstructured":"Istituto Superiore di Sanit\u00e0 (ISS). Morbillo & Rosolia News Aggiornamento mensile. Sorveglianza Integrata del Morbillo e della Rosolia. Rapporto N\u00b0 58 - Gennaio 2020. https:\/\/www.epicentro.iss.it\/morbillo\/bollettino\/RM_News_2019_58.pdf [accessed 30 November 2023]."},{"key":"10.1016\/j.vaccine.2024.05.060_b0130","unstructured":"Istituto Superiore di Sanit\u00e0 (ISS). Le vaccinazioni in Italia, 2022. https:\/\/www.epicentro.iss.it\/vaccini\/dati_Ita#morbillo [accessed 30 November 2023]."},{"key":"10.1016\/j.vaccine.2024.05.060_b0135","doi-asserted-by":"crossref","first-page":"e0226513","DOI":"10.1371\/journal.pone.0226513","article-title":"Towards elimination of measles and rubella in Italy: progress and challenges","volume":"14","author":"Adamo","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2024.05.060_b0140","doi-asserted-by":"crossref","first-page":"e2530","DOI":"10.1002\/psp.2530","article-title":"Immigrants' spatial concentration: Region or locality attractiveness?","volume":"28","author":"Vi\u00f1uela","year":"2022","journal-title":"Popul Space Place"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.060_b0145","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax080","article-title":"Sanitary Bureau of the Asylum Seekers Center of Castelnuovo di Porto. Susceptibility to measles in migrant population: implication for policy makers","volume":"25","author":"Ceccarelli","year":"2018","journal-title":"J Travel Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:09:11Z","timestamp":1737583751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":29,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0264410X24006376"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of measles antibodies in the Italian general population in 2019\u20132020","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126012"}}